Bio-Rad Offers to Acquire Stilla Technologies for up to $275 million

Transaction To Complement Bio-Rad’s Existing Digital PCR Portfolio and Accelerate Development of Next-Generation Digital PCR Solutions

HERCULES, Calif. — [BUSINESS WIRE]  - February 13, 2025 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company has entered into a binding offer to purchase all equity interests in Stilla Technologies (“Stilla”). The acquisition remains subject to customary closing conditions, and is expected to close by the end of the third quarter of 2025. 

"Stilla’s next-generation digital PCR solutions would make a compelling and complementary addition to Bio-Rad’s best-in-class digital PCR portfolio,” said Norman Schwartz, CEO of Bio-Rad Laboratories. “Once closed, the acquisition will support our strategy to further expand our business into applied research and clinical diagnostics where customers expect a higher degree of automation and throughput capabilities.”  

Jim Barry, EVP and President of Bio-Rad’s Life Science Group, added, “Together with our planned launch of Bio-Rad’s QX Continuum™ system, the Stilla platform would allow us to serve the full range of digital PCR applications and help us meet the evolving needs of customers in genomics research and applied science.”  

Rémi Dangla, CEO of Stilla Technologies, stated, “We are thrilled with the prospect of joining Bio-Rad, a leader in the field of digital PCR. With Stilla’s passion for product development and Bio-Rad’s extensive life science expertise, operational excellence, and global reach, together we can bring substantial value to the work of applied research and biopharma customers around the globe.” 

Read more here.

stilla logo-1

Who is Stilla Technologies?

Stilla Technologies develops and markets next-generation digital PCR instruments, consumables, and assays. The company’s Nio® family of all-in-one droplet digital PCR systems aids the development of a wide range of genetic tests and molecular assays across multiple applications including liquid biopsy for oncology diagnostics, cell and gene therapy, organ transplant testing, infectious diseases, and food and environmental testing. Stilla Technologies' systems are implemented worldwide, with a presence in the US, China, and Europe.

image (1)

The Nio® Family – The Next Generation Droplet Digital PCR

All-in-One ddPCR: One Instrument. One Consumable. One Pipetting.

hubspot landing page content (2)

Simple experiment configuration

Streamlined Workflow

No more oil handling, plate transfers, or unnecessary steps. The Nio®+ simplifies Droplet Digital PCR with an effortless, all-in-one workflow. Take advantage of continuous loading, allowing multiple users to run experiments throughout the day. Remote access further enhances convenience and flexibility, ensuring efficiency has never been this effortless. 

Every detail, fully revealed 1

High Capacity, Compact Design

Spend just 5 minutes on hands-on time and let the Nio®+ handle the rest. Process up to 768 samples in 24 hours and take advantage of continuous loading—allowing multiple users to run experiments throughout the day. All packed into the most compact footprint: just 56cm x 67cm.

Up to 21 targets

21 Target Detection, High Precision

Detect and quantify up to 21 genetic targets in a single reaction with the Nio® 7-Color Digital PCR System. Its advanced 7-color detection technology enables simultaneous analysis of complex mutations, gene amplifications, and deletions, delivering unmatched multiplexing and precision.

Unparalleled speed

In-silico design (ISD)

person add

See What Experts Are Saying

From oncology to cell & gene therapy to microbiology, our technology is making an impact across multiple fields. Hear from industry experts who trust and use our product!  
Dr. Alexandra Lepagnol from CHU Rennes
Adrien Savy from Coave Therapeutics
Antonio Salgado-Somoza from Exothera
Request a demo

Let us introduce you to the Nio® family!

We will show you how the Nio® can seamlessly be integrated into your field of application, optimizing your workflow and delivering precise detection in no time!